46 related articles for article (PubMed ID: 19843667)
1. Evaluation of an ELISA for p16INK4a as a screening test for cervical cancer.
Balasubramanian A; Hughes J; Mao C; Ridder R; Herkert M; Kiviat NB; Koutsky LA
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3008-17. PubMed ID: 19843667
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a new p16(INK4A) ELISA test and a high-risk HPV DNA test for cervical cancer screening: results from proof-of-concept study.
Mao C; Balasubramanian A; Yu M; Kiviat N; Ridder R; Reichert A; Herkert M; von Knebel Doeberitz M; Koutsky LA
Int J Cancer; 2007 Jun; 120(11):2435-8. PubMed ID: 17294450
[TBL] [Abstract][Full Text] [Related]
3. Comparison of p16INK4A and Hybrid Capture 2 human papillomavirus testing as adjunctive tests in liquid-based gynecologic SurePath preparations.
Nassar A; O'Reilly K; Cohen C; Siddiqui MT
Diagn Cytopathol; 2008 Mar; 36(3):142-8. PubMed ID: 18232003
[TBL] [Abstract][Full Text] [Related]
4. Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results.
Reuschenbach M; Clad A; von Knebel Doeberitz C; Wentzensen N; Rahmsdorf J; Schaffrath F; Griesser H; Freudenberg N; von Knebel Doeberitz M
Gynecol Oncol; 2010 Oct; 119(1):98-105. PubMed ID: 20619445
[TBL] [Abstract][Full Text] [Related]
5. Identification of high-grade cervical dysplasia by the detection of p16INK4a in cell lysates obtained from cervical samples.
Wentzensen N; Hampl M; Herkert M; Reichert A; Trunk MJ; Poremba C; Ridder R; von Knebel Doeberitz M
Cancer; 2006 Nov; 107(9):2307-13. PubMed ID: 17029280
[TBL] [Abstract][Full Text] [Related]
6. Enzyme-linked immunosorbent assay for p16(INK4a) - a new triage test for the detection of cervical intraepithelial neoplasia?
Jentschke M; Lange V; Soergel P; Hillemanns P
Acta Obstet Gynecol Scand; 2013 Feb; 92(2):160-4. PubMed ID: 23072258
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
8. Use of Cytology, E6/E7 mRNA, and p16INK4a-Ki-67 to Define the Management of Human Papillomavirus (HPV)-Positive Women in Cervical Cancer Screening.
Gustinucci D; Giorgi Rossi P; Cesarini E; Broccolini M; Bulletti S; Carlani A; D'angelo V; D'amico MR; Di Dato E; Galeazzi P; Malaspina M; Martinelli N; Spita N; Tintori B; Giaimo MD; Passamonti B
Am J Clin Pathol; 2016 Jan; 145(1):35-45. PubMed ID: 26712869
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia.
Ishikawa M; Fujii T; Saito M; Nindl I; Ono A; Kubushiro K; Tsukazaki K; Mukai M; Nozawa S
Int J Gynecol Cancer; 2006; 16(1):347-53. PubMed ID: 16445657
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
11. Aptima HPV Assay versus Hybrid Capture
Cook DA; Smith LW; Law J; Mei W; van Niekerk DJ; Ceballos K; Gondara L; Franco EL; Coldman AJ; Ogilvie GS; Jang D; Chernesky M; Krajden M
J Clin Virol; 2017 Feb; 87():23-29. PubMed ID: 27988420
[TBL] [Abstract][Full Text] [Related]
12. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
13. The study of the combination detection of HPV-DNA and p16INK4a in cervical lesions.
Huang MZ; Huang S; Li DQ; Nie XM; Li HB; Jiang XM
Med Oncol; 2011 Dec; 28 Suppl 1():S547-52. PubMed ID: 21053103
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of p16/Ki67 immunostaining in the triage of women referred to colposcopy.
Ordi J; Sagasta A; Munmany M; Rodríguez-Carunchio L; Torné A; del Pino M
Cancer Cytopathol; 2014 Mar; 122(3):227-35. PubMed ID: 24757722
[TBL] [Abstract][Full Text] [Related]
15. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
16. p16(INK4a) immunocytochemistry in liquid-based cervical cytology: is it feasible for clinical use?
Norman I; Brismar S; Zhu J; Gaberi V; Hagmar B; Hjerpe A; Andersson S
Int J Oncol; 2007 Dec; 31(6):1339-43. PubMed ID: 17982660
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of enzyme-linked immunosorbent assay plasma p16INK4a protein in squamous cell carcinoma in uterine cervix: A case-control study.
Raju K; Raghuveer CV; Sheela SR; Natarajan A; Jagadish TV; Sunil BN; Sharat B
J Cancer Res Ther; 2022; 18(1):152-157. PubMed ID: 35381777
[TBL] [Abstract][Full Text] [Related]
18. P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis.
Bu J; Li H; Liu LH; Ouyang YR; Guo HB; Li XY; Xiao T
Int J Clin Exp Pathol; 2014; 7(9):6091-6. PubMed ID: 25337256
[TBL] [Abstract][Full Text] [Related]
19. Development and Evaluation of p16 based Double Antibody Sandwich ELISA for Detection of Cervical Precancer and Cancer.
Bose M; Sunder Singh S; Ganesharaja S; Chiwate AS; Hingmire SJ; Rajkumar T
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2337-2346. PubMed ID: 37505764
[TBL] [Abstract][Full Text] [Related]
20. Randomised study of HPV prevalence and detection of CIN2+ in vaginal self-sampling compared to cervical specimens collected by medical personnel.
Gustavsson I; Aarnio R; Berggrund M; Hedlund-Lindberg J; Sanner K; Wikström I; Enroth S; Olovsson M; Gyllensten U
Int J Cancer; 2019 Jan; 144(1):89-97. PubMed ID: 29943822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
